HealthDay News — For patients treated with nicotinamide, the risk for skin cancer is reduced, especially when initiated after ...

Researchers investigated the association between lifestyle changes after screening for colonoscopy and the development of ...

Researchers analyzed data from the FAERS to determine the prevalence of interstitial lung disease among patients with cancer receiving antibody-drug conjugates ...

Rinatabart sesutecan is an investigational folate receptor alpha-directed, topoisomerase I inhibitor antibody-drug conjugate.

Study results suggest that “clinicians may be unaware of important clinical trial limitations identified by the FDA when making prescribing decisions,” researchers wrote.

Researchers sought to determine whether adding tafasitamab to lenalidomide plus rituximab would maintain quality of life outcomes for patients with FL.

Medicare Part D plans increased cost-sharing through higher deductibles and greater reliance on coinsurance for nonspecialty, brand-name drugs,” the researchers wrote.

Compared to standard RTOG 1112 dosing, this model reduced liver toxicity risk while maintaining tumor control in most scenarios.

Hysterectomy and hormone therapy produce similar survival outcomes in patients with early-stage endometrial cancer if they are younger than 40 years of age but not if they are 40-49 years of age.

Each additional Geriatric Oncology-PIM linked to 66 percent increase in odds of being mildly, moderate-to-severely frail at diagnosis.

The various roles for oncology nurses in the conduct of clinical trials were described in a presentation at the 2025 ONS Bridge virtual meeting.

This presentation at the 2025 ONS Bridge virtual meeting discussed the need for technologic resources and what is available for AYA cancer survivors.